
OpenEvidence
OpenEvidence is a platform that provides healthcare professionals with easy access to evidence-based clinical information. It offers trusted resources such as content from The New England Journal of Medicine, helping improve patient care decisions.
NewsHeat chart
- Week
- Month
- Year
- Media news
- Corp news
The data in the chart above is based on data derived from our proprietary XP calculation model and may be changed, adjusted and updated without prior notice
Company Valuation
- Valuation
- Share Price
- Cumulative Funding
The data in the tables and charts is based on data from public sources and although we make every effort to compile the data, it may not coincide with the actual data of the issuer.
*** - To view the data, please log into your account or create a new one.
Company valuation calculator
To calculate, specify one of the parameters
News related to OpenEvidence83
OpenEvidenceOneOncology and OpenEvidence Partner to Improve Cancer Care ...
In the United States, more than half of hematology/oncology physicians already use OpenEvidence to help inform their clinical decisions. Community physicians at ...
https://www.streetinsider.com/Press+Releases/OneOncology+and+OpenEvidence+Partner+to+Improve+Cancer+Care+Nationwide/26880325.html
OpenEvidenceSpringer Nature and OpenEvidence Announce Agreement to ...
Content to be available at point of critical need for medical professionals. NEW YORK & MIAMI--(BUSINESS WIRE)-- Springer Nature and OpenEvidence today ...
http://www.streetinsider.com/Business+Wire/Springer+Nature+and+OpenEvidence+Announce+Agreement+to+Maximise+Exposure+of+Trusted+Findings+On+OpenEvidence+Platform/26870559.html
OpenEvidenceA new medical AI study found the same flaw in OpenEvidence ...
OpenEvidence, founded in 2021, is a free, ad-supported AI search engine for doctors that pulls answers straight from peer-reviewed medical journals at the ...
https://fortune.com/2026/07/29/new-medical-ai-study-same-flaw-openevidence-openai-anthropic-doximity/
OpenEvidenceOpenEvidence atteint un chiffre d'affaires annualisé de 300 millions ...
OpenEvidence a clôturé l'année 2025 avec un taux de revenus annualisés d'environ 150 millions de dollars. Le marché de la publicité pharmaceutique représente ...
https://fr.investing.com/news/stock-market-news/openevidence-atteint-un-chiffre-daffaires-annualise-de-300-millions-de-dollars-93CH-3506025
OpenEvidenceOpenEvidence atinge taxa de receita anualizada de US$ 300 ...
Parte da receita da OpenEvidence pode vir de contratos corporativos com sistemas de saúde, o que seria adicional ao mercado farmacêutico de US$ 3 bilhões, ...
https://br.investing.com/news/stock-market-news/openevidence-atinge-taxa-de-receita-anualizada-de-us-300-milhoes-diz-bank-of-america-93CH-2006842
Show more (78)Investors1
Sequoia Capital